DeepMind has introduced AlphaGenome, a groundbreaking DNA sequence model designed to enhance the prediction of regulatory variant effects. This innovative tool aims to provide deeper insights into genome functionality, thereby advancing the field of genomics. Available via API, AlphaGenome represents a significant step forward in the application of artificial intelligence to biological research, allowing researchers and institutions to leverage its capabilities for a better understanding of genetic variations. The implications of this technology extend beyond academia, potentially transforming the landscape of personalized medicine and genetic engineering.
Source: DeepMind
